Press release
29 March 2007
BioGaia signs agreement in USA
BioGaia has signed an agreement with Everidis Health Sciences LLC which gives
Everidis the rights to sell BioGaia Probiotic drops, chewable tablets and straws
in the USA. The products will be sold under the BioGaia brand to pharmacies and
doctors throughout the USA. Launch is expected during the later part of 2007.
Everidis is a subsidiary of Nutraceutics Corporation who has been active in the
area of dietary supplements since 1994. Everidis are specialists in sales
through pharmacies and doctors.
BioGaia´s clinical studies have generated major interest in the USA and have
made it possible to find a distributor who will invest in BioGaia´s own
developed products under the BioGaia brand.
”This is an important step in our strategic investment in our own brand.
Together with Everidis, we will invest in PR prior to the launch. Probiotic
products and their positive effects on health are getting increasing recognition
in the American media and consumers are showing more and more interest in these
products”, says Peter Rothschild, CEO BioGaia AB.
”BioGaia´s products are well-suited in our commitment to well-documented
products for mothers and children” says Jennifer Cherry, President Everidis
Health Sciences.
Latest press releases from BioGaia:
2007-03-22 Notice of Annual General Meeting
2007-03-05 BioGaia signs new agreement with Semper
2007-02-21 BioGaia signs agreement with Delta Medical
For additional information contact:
Peter Rothschild, president, telephone: +46 (0)8 - 555 293 00
Jan Annwall, executive vice president, telephone: +46 (0)8 - 555 293 00
--------------------------------------------------------------------------------
-----------------------------------------------------------
BioGaia is a biotechnology company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has
health-enhancing effects. The class B share of the Parent Company BioGaia AB is
quoted on the Small Cap list of the Nordic Exchange in Stockholm.
www.biogaia.com